Histamine Receptor H1–Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome

Cited by (372)

Items 201–300 of 372

1. Why are disorders of gut–brain interaction (DGBI) often food-related? Duodenal eosinophils and mast cells, small intestinal bacteria, food allergy and altered food intake in functional dyspepsia and the irritable bowel syndrome: a new paradigm
   Nicholas Joseph Talley, Kerith Duncanson, Georgina M. Williams · 2025 · Journal of Gastroenterology
2. Coffee, Alcohol, and Artificial Sweeteners Have Temporal Associations with Gastrointestinal Symptoms
   Egbert Clevers, Darren Launders, Damian Helme, Sanna Nybacka, Stine Störsrud, Maura Corsetti, Lukas Van Oudenhove, Magnus Simrén, Jan F. Tack · 2024 · Digestive Diseases and Sciences
3. Adenosine A2B Receptors: An Optional Target for the Management of Irritable Bowel Syndrome with Diarrhea?
   Teita Asano, Mitsuko Takenaga · 2017 · Journal of Clinical Medicine
4. Irritable bowel syndrome is strongly associated with the primary and idiopathic mast cell disorders
   Michael Kurin, Abbinaya Elangovan, Muhammed Mustafa Alikhan, Basmah Al Dulaijan, Eli Silver, David C. Kaelber, Gregory S. Cooper · 2021 · Neurogastroenterology & Motility
5. Nightshade Vegetables: A Dietary Trigger for Worsening Inflammatory Bowel Disease and Irritable Bowel Syndrome?
   Rebecca R. Kuang, David J. Levinthal, Amir A. Ghaffari, Claudia Ramos Rivers, Aylin Tansel, David G. Binion · 2023 · Digestive Diseases and Sciences
6. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial
   Yan Wang, Yongquan Huang, Shui-lian Zhu, Changrong Zhang, Xinlin Chen, Qiuke Hou, Fengbin Liu · 2020 · Trials
7. An Overview of the Effects of Tenapanor on Visceral Hypersensitivity in the Treatment of Irritable Bowel Syndrome with Constipation
   Prashant Singh, Gregory S. Sayuk, David P. Rosenbaum, Susan A. Edelstein, Kenji Kozuka, Lin Chang · 2024 · Clinical and Experimental Gastroenterology
8. An Allergic Basis for Abdominal Pain
   Marc E. Rothenberg · 2021 · New England Journal of Medicine
9. Efficacy and Safety of Non-brain Penetrating H1-Antihistamines for the Treatment of Allergic Diseases
   Kazuhiko Yanai, Takeo Yoshikawa, Martin K. Church · 2021 · Current topics in behavioral neurosciences
10. Overlap between irritable bowel syndrome and hypermobile Ehlers–Danlos syndrome: An unexplored clinical phenotype?
    Anisa Choudhary, Asma Fikree, Qasim Aziz · 2021 · American Journal of Medical Genetics Part C Seminars in Medical Genetics
11. Electropolymerized Receptor Coatings for the Quantitative Detection of Histamine with a Catheter-Based, Diagnostic Sensor
    Gideon Wackers, Peter Cornelis, Tristan Putzeys, Marloes Peeters, Jan F. Tack, Freddy J. Troost, Theodor Doll, Nicolas Verhaert, Patrick Wagner · 2020 · ACS Sensors
12. Mucosal eosinophils, mast cells, and intraepithelial lymphocytes in youth with rumination syndrome
    Hunter J. Friesen, John M. Rosen, Christina Low Kapalu, Meenal Singh, Tracy Spaeth, Jose T. Cocjin, Craig A. Friesen, Jennifer V. Schurman · 2021 · Neurogastroenterology & Motility
13. Neurophysiologic Mechanisms of Human Large Intestinal Motility ☆
    Adil E. Bharucha, Simon J. Brookes · 2018 · Elsevier eBooks
14. Les dosages d’IgG anti-aliments : méthodes et pertinence clinique des résultats. Position du groupe de travail de biologie de la Société française d’allergologie
    H. Chabane, Virginie Doyen, F. Bienvenu, Karine Adel‐Patient, Joana Vitte, Delphine Mariotte, Jacques Bienvenu · 2018 · Revue française d'allergologie
15. MRGPRX2 Mediates Mast Cell‐Induced Endometriosis Pain Through the Sensitization of Sensory Neurons via Histamine/ HRH1 / TRPV1 Signaling Pathway
    Xinqi Mao, Jianzhang Wang, Shaojie Ding, Xinyue Guo, Xinxin Xu, Ping Xu, Xinmei Zhang · 2025 · The FASEB Journal
16. Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs
    Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Reza Abdollahi · 2024 · Expert Opinion on Investigational Drugs
17. Pain is a cardinal symptom cutting across Rome IV anatomical categories in disorders of gut‐brain interaction: A network‐based approach
    Helen Burton Murray, Livia Anna Guadagnoli, Irina A. Vanzhula, Tiffany A. Brown, Ami David Sperber, Olafur Steinn Palsson, Shrikant I. Bangdiwala, Lukas Van Oudenhove, Kyle D. Staller · 2024 · Neurogastroenterology & Motility
18. Acute stress induces visceral hypersensitivity via glucocorticoid receptor–mediated membrane insertion of TRPM8: Involvement of a non‐receptor tyrosine kinase Pyk2
    Qingqing Luo, Bo Wang, Xin Chen, Hong-Yi Qiu, Wenting Li, Xiu‐Juan Yan, Shengliang Chen · 2020 · Neurogastroenterology & Motility
19. Histamine Neuroimaging in Stress-Related Disorders
    Shin Fukudo, Michiko Kano, Yasuhiro Sato, Tomohiko Muratsubaki, Motoyori Kanazawa, Manabu Tashiro, Kazuhiko Yanai · 2021 · Current topics in behavioral neurosciences
20. Possible therapeutic role of IgE blockade in irritable bowel syndrome
    Eli Magen, Tinatin Chikovani · 2016 · World Journal of Gastroenterology
21. Local immune response as novel disease mechanism underlying abdominal pain in patients with irritable bowel syndrome
    Javier Aguilera‐Lizarraga, Morgane V. Florens, Hind Hussein, Guy E. Boeckxstaens · 2021 · Acta Clinica Belgica
22. Gastroparesis syndromes: emerging drug targets and potential therapeutic opportunities
    Le Yu Naing, Matthew A. Heckroth, Prateek Mathur, Thomas L. Abell · 2023 · Expert Opinion on Investigational Drugs
23. Dectin‐1 induces TRPV1 sensitization and contributes to visceral hypersensitivity of irritable bowel syndrome in male mice
    Hao‐Nan Zheng, Yu‐Ru Zhi, Yang‐Shuai Su, Jin‐Yan Jiang, Hao‐Zhou Zhang, Feng Cao, Yun Wang, Yan Chi, Ying Zhang · 2024 · European Journal of Pain
24. Beyond the “Master” Role in Allergy: Insights into Intestinal Mast Cell Plasticity and Gastrointestinal Diseases
    Rosa Molfetta, Alessia Carnevale, Caterina Marangio, Erisa Putro, Rossella Paolini · 2025 · Biomedicines
25. The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal Insult
    Hannah Ceuleers, Nikita Hanning, Michelle De bruyn, Joris G. De Man, Heiko U. De Schepper, Qian Li, Liansheng Liu, Steven Abrams, Annemieke Smet, Jurgen Joossens et al. · 2022 · Frontiers in Pharmacology
26. Managing pain in irritable bowel syndrome: current perspectives and best practice
    Joost P. Algera, Jenny Lövdahl, Jessica Sjölund, Navkiran Thind Tornkvist, Hans Törnblom · 2023 · Expert Review of Gastroenterology & Hepatology
27. Metabolic biomarkers in irritable bowel syndrome diagnosis
    Omid Vakili, Peyman Adibi Sedeh, Morteza Pourfarzam · 2024 · Clinica Chimica Acta
28. Sexually Dimorphic Effects of Histamine Degradation by Enteric Glial Histamine N-Methyltransferase (HNMT) on Visceral Hypersensitivity
    Jonathon Lee McClain, Wilmarie Morales‐Soto, Jacques A. Gonzales, Visha Parmar, Elena Y. Demireva, Brian David Gulbransen · 2023 · Biomolecules
29. Reizdarm und Reizmagen – Pathophysiologie und Biomarker
    Michael Schemann · 2017 · Die Gastroenterologie
30. Cognitive-Behavioral Therapy for Irritable Bowel Syndrome
    Melissa G. Hunt · 2019 · Springer eBooks
31. In Vitro Recording of Mesenteric Afferent Nerve Activity in Mouse Jejunal and Colonic Segments
    Sara Nullens, Annemie Deiteren, Wen Yi Jiang, Christopher D. Keating, Hannah Ceuleers, Sven Francque, David Grundy, Joris G. De Man, Benedicte Y. De Winter · 2016 · Journal of Visualized Experiments
32. Exploring the potential targets of Biling Weitong Granules on visceral hypersensitivity through integration of network pharmacology and in vivo analysis
    Qidi Yang, Yizhou Zhao, Xiangyu Zhao, Sishen Sun, Yifei Chen, Jiayin Chen, Duowu Zou, Ling Zhang · 2023 · Journal of Ethnopharmacology
33. The roles of transient receptor potential vanilloid in autoimmune diseases
    Yu Xiao, Xin Yue, Kai Shen, Ming Yang, Haijing Wu · 2025 · Autoimmunity Reviews
34. Unraveling functional dyspepsia: Pathophysiological mechanisms, microbiota interactions, and emerging therapeutic strategies
    Aisi Huang, Bixia Lin, Tao Hu, Jiao Xia Lan · 2025 · Pathology - Research and Practice
35. Parafascicular nucleus circuits: Implications for the alteration of gastrointestinal functions during epileptogenesis
    Maohui Feng, Zhigang He, Baowen Liu, Zhixiao Li, Duozhi Wu, Sanguang Liu, Hong‐Bing Xiang · 2016 · Epilepsy & Behavior
36. Contribution of the Enteric Nervous System to Autoimmune Diseases and Irritable Bowel Syndrome
    Anita Annaházi, Michael Schemann · 2022 · Advances in experimental medicine and biology
37. The Evolving Role of Mucosal Histology in the Evaluation of Pediatric Functional Dyspepsia: A Review
    Craig A. Friesen, Jennifer Marie Colombo, Jennifer V. Schurman · 2019 · Gastrointestinal Disorders
38. Pain-like behaviors and local mechanisms involved in the nociception experimentally induced by Latrodectus curacaviensis spider venom
    Pedro Santana Sales Lauria, Luciana Lyra Casais-e-Silva, Renan Fernandes do Espírito Santo, Cláudio Maurício Vieira de Souza, Russolina B. Zingali, Marjolly B. Caruso, Milena Botelho Pereira Soares, Cristiane Flora Villarreal · 2018 · Toxicology Letters
39. TRPV1 Sensory Neurons and Enteric Glia in ENS Link Tachykinins to Neuroinflammation and Nociception
    Fievos L. Christofi · 2018 · Cellular and Molecular Gastroenterology and Hepatology
40. Review of the Patient Burden and Therapeutic Landscape of Irritable Bowel Syndrome with Constipation in the United States
    M. S. Sendzischew-Shane, Johannah Ruddy, Michael Cline, David P. Rosenbaum, Susan Edelstein, B. Moshiree · 2024 · Clinical and Experimental Gastroenterology
41. Mast cells in digestive diseases: New insights to keep them under control
    Hayriye Akel Bilgiç, Marie Kaarup Bek, Mirelle T.A. Kleuskens, Frank A. Redegeld · 2025 · Pharmacological Research
42. Determining patient treatment preferences for management of acute pain episodes in irritable bowel syndrome
    Christopher V. Almario, Samuel A. Eberlein, Carine Khalil, Brennan Mason Ross Spiegel · 2021 · Neurogastroenterology & Motility
43. Update on the Role of Allergy in Pediatric Functional Abdominal Pain Disorders: A Clinical Perspective
    Craig A. Friesen, Jennifer Marie Colombo, Jennifer V. Schurman · 2021 · Nutrients
44. Overlap of Functional Gastrointestinal Disorders: Common Mechanisms of Pathogenesis as a Key to Rational Therapy
    Мехтиев Сабир Насрединович, О. А. Мехтиева, Берко Олеся Михайловна · 2022 · Russian Journal of Gastroenterology Hepatology Coloproctology
45. Pharmacological approaches to treat intestinal pain
    Mikołaj Świerczyński, Adam Makaro, Agata Grochowska, Maciej Sałaga · 2023 · Expert Review of Clinical Pharmacology
46. Maternal separation leads to dynamic changes of visceral hypersensitivity and fecal metabolomics from childhood to adulthood
    Xiaolong Chen, Chenmin Hu, Chenxi Yan, Enfu Tao, Zhenya Zhu, Xiaoli Shu, Rui Chen Guo, Mizu Jiang · 2023 · Scientific Reports
47. Chronic Sacral Nerve Stimulation Inhibits Visceral Hypersensitivity in Diarrhea–Predominant Irritable Bowel Syndrome Rats Model
    Xiaojuan Guo, Changsheng Lei, Hanwei Liang, Jiaxu An, Yanbin Fang, Xiaolu Zhang, Zhiyan Wang, Chunhua Hu, Xuan Jiang · 2023 · Neuromodulation Technology at the Neural Interface
48. Efficacy of Drugs Acting on Histamine 1 Receptors in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis
    Mais Khasawneh, Christopher J. Black, Alexander Charles Ford · 2024 · Gastroenterology
49. Psychological Status and Irritable Bowel Syndrome among Healthcare Workers
    Zeinab Abdel Aziz Kasemy, Ayman Ahmed Sakr, EL Shebiny M, A Elbasyouny, Mervat Mohamed El Dalatony · 2020 · Egyptian Journal of Occupational Medicine
50. 367 Visceral Hypersensitivity is Associated With GI Symptom Severity in Functional GI Disorders: Consistent Findings From Five Different Patient Cohorts
    Magnus Simrén, Hans Törnblom, Olafur Steinn Palsson, Miranda A.L. van Tilburg, Lukas Van Oudenhove, Jan F. Tack, William E. Whitehead · 2016 · Gastroenterology
51. From pain to meningitis: bacteria hijack nociceptors to promote meningitis
    Huazhen Liu, Xingxing Kong, Yuqin Zeng, Jinyun Chen, Zhanpeng Chen, Lanlan Liu, Quan Ma, Xuhui Liu, Shuihua Lu · 2025 · Frontiers in Immunology
52. A Survey of Methodologies for Assessing Mast Cell Density and Activation in Patients with Functional Abdominal Pain Disorders
    Hunter J. Friesen, Meenal Singh, Vivekanand Singh, Jennifer V. Schurman, Craig A. Friesen · 2021 · Gastrointestinal Disorders
53. Immune-mediated food reactions in irritable bowel syndrome
    Hind Hussein, Guy E. Boeckxstaens · 2022 · Current Opinion in Pharmacology
54. Losartan attenuates acetic acid enema-induced visceral hypersensitivity by inhibiting the ACE1/Ang II/AT1 receptor axis in enteric glial cells
    Yating Sun, Xiaohui Liu, Lianli Wang, Laifu Li, Xiaojing Quan, Haitao Shi, Ting Wang, Lin Mei, Yindi Chen, Yue Zhang et al. · 2023 · European Journal of Pharmacology
55. Meal related symptoms in youth with chronic abdominal pain: Relationship to anxiety, depression, and sleep dysfunction
    Achintya Benegal, Hunter J. Friesen, Jennifer V. Schurman, Jennifer Marie Colombo, Craig A. Friesen · 2024 · Journal of Pediatric Gastroenterology and Nutrition
56. Emerging studies of human visceral nociceptors
    David E. Reed, Stephen J. Vanner · 2016 · American Journal of Physiology-Gastrointestinal and Liver Physiology
57. Review article: current and future treatment approaches for IBS with constipation
    Joy J. Liu, Darren M. Brenner · 2021 · Alimentary Pharmacology & Therapeutics
58. Research hotspots and trends in visceral pain research: A global comprehensive bibliometric analysis
    Le Guan, Yang Liu, Bin Wu, Aiqin Chen, Wucheng Tao, Chun Lin · 2023 · Frontiers in Molecular Neuroscience
59. Novel insights in the pathophysiology and management of functional dyspepsia
    Tim Vanuytsel · 2023 · Acta gastro-enterologica belgica
60. Role of microbiota in pain: From bench to bedside
    Huiguang Ren, Bo Cao, Qixuan Xu, Ruiyang Zhao, Hanghang Li, Bo Wei · 2025 · iMetaOmics.
61. All in my head or all in my gut? An update on irritable bowel syndrome.
    Amy Woods, Alexander C. Ford, C. Black · 2025 · Current Opinion in Gastroenterology
62. Pathophysiology of irritable bowel syndrome
    Yasmin Nasser, Andrea Shin, Alexander Charles Ford, Michael Camilleri, Christopher J. Black · 2026 · The Lancet. Gastroenterology & hepatology
63. Motility index measured by magnetic resonance enterography is associated with sex and mural thickness
    Sven Månsson, Olle Ekberg, Bodil Ohlsson · 2020 · World Journal of Gastroenterology
64. Practical approach to irritable bowel syndrome-diarrhea beyond low-FODMAP diet
    Constanza Ciriza de los Ríos, Marta Aparicio Cabezudo, Ana Zatarain Vallés, Enrique Rey · 2022 · Revista Española de Enfermedades Digestivas
65. Increased Allergic Rhinitis Prevalence and Symptom Severity in Patients With Irritable Bowel Syndrome
    María Cuende‐Estévez, Hind Hussein, Fedrica Pia, Wout Backaert, Laura Van Gerven, Javier Aguilera‐Lizarraga, Guy E. Boeckxstaens · 2025 · Neurogastroenterology & Motility
66. Novel insight in diarrhoea-predominant IBS: miRNAs modulate barrier function
    Mira M. Wouters · 2017 · Gut
67. Efficacy of mast cell directed therapies in irritable bowel syndrome: a systematic review
    D Coppens, M Kips, T Stiévenard, Christel H. Mertens, Heiko U. De Schepper · 2024 · Acta gastro-enterologica belgica
68. Irritable bowel syndrome and the gut microbiota
    Phoebe E. Heenan, Jacqueline Ilene Keenan, Simone Birgit Bayer, Myrthe Simon, Richard Blair Gearry · 2019 · Journal of the Royal Society of New Zealand
69. Utility of quantifying mast cells in gastrointestinal biopsies in patients with suspected mast cell activation disorder
    Rachel Odin, Simin Zhang, Nives Zimmermann, Jonathan A. Bernstein · 2025 · Annals of Allergy Asthma & Immunology
70. MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemia
    Michelle Galeas‐Pena, Jonathan J. Lyons, Dhana Llivichuzhca-Loja, Steve Everman, Ghina Yaghi, Katelyn White, Sangita Sutradhar, Tanya O. Robinson, Anna H. Owings, Neha S. Dhaliwal et al. · 2026 · Frontiers in Allergy
71. Histamine intolerance and irritable bowel syndrome
    Yu.A. Golubeva, Anna F. Sheptulina, Oksana M. Drapkina · 2023 · Russian Journal of Preventive Medicine
72. Three-dimensional imaging and computational quantitation as a novel approach to assess nerve fibers, enteric glial cells, mast cells, and the proximity of mast cells to the nerve fibers in human sigmoid mucosal biopsies from healthy subjects
    Pu‐Qing Yuan, Tao Li, Swapna Mahurkar‐Joshi, Jessica Sohn, Lin Chang, Yvette Taché · 2025 · Journal of Neuroscience Methods
73. Live Imaging of Primary Neurons in Long-Term Cryopreserved Human Nerve Tissue
    Marina Fortea, Piyush Jain, Ingrid Demedts, Jan F. Tack, Tim Vanuytsel, Carla Cirillo, Pieter Vanden Berghe · 2021 · eNeuro
74. Overactive bladder syndrome symptoms in youth with abdominal pain-associated disorders of gut–brain interaction
    Hunter J. Friesen, Pierce Thompson, Jennifer V. Schurman, Jennifer Marie Colombo, Craig A. Friesen · 2023 · Scientific Reports
75. Partners in Pain: New Insights into The Role of CGRP Signaling in Cross-Organ Sensitization
    Matthew D. Coates, Margaret A. Vizzard · 2023 · Journal of Pharmacology and Experimental Therapeutics
76. Visceral Sensitivity
    Christophe C. Faure, Franziska Righini‐Grunder · 2016 · Springer eBooks
77. Immune activation in irritable bowel syndrome: from basic to clinic
    Mohammad Bashashati · 2017 · NeuroGastroLATAM Reviews
78. Visceral Pain
    David Colin Bulmer, Carolina Roza · 2018 · Oxford University Press eBooks
79. Editorial: increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome
    Sean Bennet, Hans Törnblom · 2017 · Alimentary Pharmacology & Therapeutics
80. Neurite outgrowth in symptomatic uncomplicated diverticular disease
    Veronica De Simone, Lies van Baarle, Gianluca Matteoli · 2019 · Neurogastroenterology & Motility
81. Emerging therapeutic approaches for treating abdominal pain
    Nestor Nivardo Jiménez-Vargas, Nabil Parkar, Kaede Takami, Hannah M Wood, Alan E. Lomax, David E. Reed, Stephen J. Vanner · 2025 · Journal of the Canadian Association of Gastroenterology
82. Cold-inducible RNA-binding protein promotes gut barrier dysfunction and visceral hypersensitivity via activating mast cells in IBS-D
    Tao Wang, Peiwen Yang, Siyuan Dong, Xin Qi He, Fei Dai, Jinhai Wang, Yi Lyu, Rongqian Wu, Jia Zhang · 2025 · International Immunopharmacology
83. Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders
    Fleur Veldman, Christopher J. Black, Andrea Shin, Dániel Keszthelyi · 2026 · British Journal of Pharmacology
84. Irritable Bowel Syndrome Clinical Care Gaps and the Potential of Future Therapeutics Based on Peripheral Visceral Afferent Modulation
    Michael Camilleri · 2026 · Clinical Gastroenterology and Hepatology
85. Neuro-immune-epithelial pathways involving substance P may contribute to mucosal pathology in gastro-oesophageal reflux disease
    Tom Leech, Philip J. Woodland, Madusha Peiris · 2026 · Frontiers in Immunology
86. When Eating Becomes a Pain in the Gut
    Taylor Adair, Gabrielle Therese Belz · 2021 · Trends in Immunology
87. The food, the bug, and the ugly: A recipe for food‐induced gut pain
    Liam Emile Rondeau, Giada De Palma, Alberto Caminero · 2021 · Allergy
88. Asia Syndrome and Breast Implants, Report of A Case and Review of The Literature
    Vargas Hernández Victor Manuel · 2023
89. Ebastine for the treatment of irritable bowel syndrome: old drug, new tricks?
    Alexander Charles Ford · 2024 · Gut
90. ASOCIACIÓN ESPAÑOLA DE NEUROGASTROENTEROLOGIA Y MOTILIDAD (ASENEM) UPDATED REVIEW ON THE MANAGEMENT OF FUNCTIONAL ABDOMINAL PAIN.
    Jordi Serra, A. Aguilar, E. Barba, C. C. de los Ríos, L. G. Pravia, Vicente Martínez, B. S. Falcón · 2024 · Gastroenterology & hepatology
91. A Pilot Study of Ketotifen in Patients Aged 8–17 Years with Functional Dyspepsia Associated with Mucosal Eosinophilia
    Chance S. Friesen, Valentina Shakhnovich, Paul C. Toren, Brandon Retke, Jennifer V. Schurman, Jennifer Marie Colombo, Amanda Drews Deacy, Craig A. Friesen, Susan M. Abdel‐Rahman · 2024 · Pediatric Drugs
92. Is IBS a Food Allergy? Confocal Laser Endomicroscopy Findings in Patients with IBS: A Narrative Review
    Federica Pavan, Andrea Costantino, Gian Eugenio Tontini, Luca Elli, Nicola Siragusa, Giovanni Lasagni, Marco Dubini, Alice Scricciolo, Maurizio Li Vecchi · 2025 · Applied Sciences
93. Allergies and Irritable Bowel Syndrome.
    Nicholas J. Talley · 2019 · PubMed Central
94. Does Irritable Bowel Syndrome Exist? Identifiable and Treatable Causes of Associated Symptoms Suggest It May Not
    Benjamin I. Brown · 2019 · Gastrointestinal Disorders
95. Irritable bowel syndrome with diarrhea: Treatment is a work in progress
    Michael Kurin, Gregory S. Cooper · 2020 · Cleveland Clinic Journal of Medicine
96. Irritable bowel syndrome: what's new? (UEG Week Virtual 2020 materials review)
    Olga V. Gaus, Maria A. Livzan · 2021 · Medical alphabet
97. Emerging therapies in the management of Irritable Bowel Syndrome (IBS)
    Jill E. Elwing, Hadi Atassi, Benjamin D. Rogers, Gregory S. Sayuk · 2022 · Expert Opinion on Emerging Drugs
98. Neuroactive changes in the bowel of patients with IBS on low FODMAP diet: another piece of the puzzle
    David Colin Bulmer · 2023 · Gut
99. Editorial: diet, inflammation and irritable bowel syndrome
    Eamonn M.M. Quigley · 2017 · Alimentary Pharmacology & Therapeutics
100. Autoimmune/Inflammatory Syndrome Induced by Adjuvants ( ASIA or Shoenfeld's Syndrome) Due to Polypropylene Mesh Implants
     Jan Willem Cohen Tervaert, Mohammed S. Osman · 2024 · Wiley eBooks